Concurrent chemoradiation for patients with squamous cell carcinoma of the cervical esophagus

Diseases of the Esophagus

Volumn 20, Issue 1, 2007, Pages 12-18

  Uno, Tashi ^a   Isobe, K ^a   Kawakami, H ^a   Ueno, N ^a   Shimada, H ^a   Matsubara, H ^a   Okazumi, S ^a   Nabeya, Y ^a   Shiratori, T ^a   Kawata, T ^a   Ochiai, T ^a   Ito, H ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Cervical esophagus; Cisplatin; Concurrent chemoradiation; Esophageal cancer; Radiation therapy

Indexed keywords

CISPLATIN; FLUOROURACIL; SEROTONIN 3 ANTAGONIST;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTINUOUS INFUSION; ESOPHAGITIS; ESOPHAGUS CARCINOMA; ESOPHAGUS SURGERY; FEMALE; HUMAN; LEUKOPENIA; MALE; MEDICAL RECORD REVIEW; NAUSEA; NEPHROTOXICITY; PHARYNGITIS; PRIORITY JOURNAL; RADIATION DOSE; RETROSPECTIVE STUDY; SKIN MANIFESTATION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT PLANNING; VOMITING;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES;

EID: 33846246230     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2007.00632.x     Document Type: Article

References (18)

1. The Japanese Society for Esophageal Disease. Comprehensive registry of esophageal cancer in Japan (1998, 1999) & long-term results of esophagectomy in Japan (1988-1977). 3rd edn. Tokyo: The Japanese Society for Esophageal Disease, 2002.
2. Yin W B, Zhang L, Miao Y et al. The results of high-energy electron therapy in carcinoma of the oesophagus compared with telecobalt therapy. Clin Radiol 1983; 34: 113-6.
3. Mendenhall W M. Carcinoma of the Cervical Esophagus. In: Million RR, Cassisi NJ, (eds). Management of Head and Neck Cancer: A Multidisciplinary Approach, 2nd edn. Philadelphia: J.B. Lippincott, 1984; 393-406.
4. Burdette W J, Jesse R. Carcinoma of the cervical esophagus. J Thorac Cardiovasc Surg 1972; 63: 41-53.
5. Kakegawa T, Yamana H, Ando N. Analysis of surgical treatment for carcinoma situated in the cervical esophagus. Surgery 1985; 97: 150-7.
6. Therasse P, Arbuck S G, Eisenhauer E A et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: 205-16.
7. Tahara M, Ohtsu A, Hironaka S et al. Clinical impact of criteria for complete response (CR) of primary site to treatment of esophageal cancer. Jpn J Clin Oncol 2005; 35: 316-23.
8. Schecter G, Kalafsky J. Cancer of the hypopharynx and cervical esophagus: Management concepts. Oncology 1988; 2: 17-24.
9. Triboulet J P, Mariette C, Chevalier D et al. Surgical management of carcinoma of the hypopharynx and cervical esophagus: Analysis of 209 cases. Arch Surg 2001; 136: 1164-70.
10. Goodner J T. Treatment and survival in cancer of the cervical esophagus. Am J Surg 1969; 118: 673-5.
11. Pearson J G. Radiotherapy for esophageal carcinoma. World J Surg 1981; 5: 489-97.
12. Mendenhall W M, Parsons J T, Vogel S B et al. Carcinoma of the cervical esophagus treated with radiation therapy. Laryngoscope 1988; 98: 769-71.
13. Mendenhall W M, Sombeck M D, Parsons J T et al. Management of cervical esophageal carcinoma. Semin Radiat Oncol 1994; 4: 179-91.
14. Herskovic A, Martz K, al-Sarraf M et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326: 1593-8.
15. Cooper J S, Guo M D, Herskovic A et al. Chemoradiotherapy of locally advanced esophageal cancer. Long-term follow-up of a prospective randomized trial (RTOG 85-01). JAMA 1999; 281: 1623-7.
16. Liao Z, Zhang Z, Jin J et al. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Int J Radiat Oncol Biol Phys 2004; 60: 1484-93.
17. Minsky B D, Pajak T F, Ginsberg R J et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modarity therapy for esophageal cancer: High-dose versus standard-dose radiation therapy. J Clin Oncol 2002; 20: 1167-74.
18. Zhang Z, Liao Z, Jin J et al. Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 2005; 61: 656-64.